Health Effects of Substituting Sugary Beverages With Artificially-sweetened Beverages or Water
Launched by BRIGHAM AND WOMEN'S HOSPITAL · Sep 22, 2020
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating whether swapping sugary drinks, like soda and sweetened fruit juices, with calorie-free options like artificially sweetened beverages or water can help people manage their weight and improve their health. The study aims to understand if these alternatives are a good choice for adults who regularly consume sugary drinks and are classified as overweight or obese.
To be eligible for the trial, participants should be between 20 and 69 years old, drink at least one sugary beverage a day, and have a body mass index (BMI) between 25 and 45. Participants will need to have a smartphone to use a study app and must be willing to follow the beverage guidelines for six months. Throughout the trial, participants will be randomly assigned to one of four groups, each with different beverage options. It’s important to note that individuals with certain health conditions or those who are pregnant or breastfeeding are not eligible to join. This study could provide valuable insights for those looking to reduce their sugar intake and improve their overall health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adults aged 20-69 years
- • 2. Consume ≥1 serving/day (12 oz.) of SSBs (SSBs include soda, fruit drinks, energy drinks, sports drinks, and sweetened waters, sweetened with high fructose corn syrup, sucrose, or fruit juices. SSBs do not include 100% fruit juice, sweetened teas, or flavored milk.)
- • 3. BMI 25.0 to 45.0 kg/m2
- • 4. Access to a smartphone and willingness and ability to download study app
- • 5. Willing to consume beverages consistent with any of the 4 possible group assignments for 6 months
- Exclusion Criteria:
- • 1. Physician diagnosis of T2D or fasting glucose ≥126 mg/dL at in-person screening visit
- • 2. Intention to move away from greater Boston area within 1 year from randomization
- • 3. Major medical illness (known cardiovascular disease, cancer, kidney disease, cirrhosis, etc.)
- • 4. Phenylketonuria (PKU)
- • 5. Medication that may affect weight or other study endpoints
- • 6. Another family or household member participating in the study
- • 7. Pregnant in the past 12 months, currently breastfeeding, or planning to become pregnant during the study period
About Brigham And Women's Hospital
Brigham and Women's Hospital (BWH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As an integral part of the Partners HealthCare system, BWH combines cutting-edge medical education with a focus on patient-centered care, fostering an environment that promotes groundbreaking clinical trials across various specialties. The hospital is dedicated to translating scientific discoveries into effective treatments, making significant contributions to the fields of cardiovascular medicine, oncology, and women's health, among others. With a robust infrastructure for research and a collaborative approach, BWH aims to improve patient outcomes and enhance the overall quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Boston, Massachusetts, United States
Patients applied
Trial Officials
Deirdre Tobias, ScD
Principal Investigator
Brigham and Women's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials